Global Retirement Partners’s Meridian Bioscience Inc VIVO Stock Holding History

Global Retirement Partners’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-79	Closed	-$2.62K	–	3393
2022 Q4	$2.62K	Hold	79	–	–	﹤0.01%	2260
2022 Q3	$3K	Buy	79 +16	+25%	+$518	﹤0.01%	2185
2022 Q2	$2K	Hold	63	–	–	﹤0.01%	2316
2022 Q1	$2K	Buy	+63	New	+$1.5K	﹤0.01%	2281

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Global Retirement Partners's VIVO Position: Q1 2023 in Review

Global Retirement Partners sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 79 shares — an estimated $2.62K sold.

Global Retirement Partners first reported a position in VIVO in Q1 2022 and held it in 4 quarters. The position peaked at $3K in Q3 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Global Retirement Partners reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Global Retirement Partners sold 79 Meridian Bioscience Inc shares in Q1 2023, an estimated $2.62K.
Global Retirement Partners first reported a position in Meridian Bioscience Inc in Q1 2022 and held it in 4 quarters.
Global Retirement Partners's Meridian Bioscience Inc position peaked at $3K in Q3 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Global Retirement Partners's 13F filing for Q1 2023, filed 8 May 2023.